share_log

華領醫藥-B:自願性公告 - 就第二代葡萄糖激酶異位激活劑向FDA提交新藥臨床試驗申請並獲受理

HUA MEDICINE-B: VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF 2nd GENERATION GLUCOKINASE ALLOSTERIC ACTIVATOR FILED WITH AND ACCEPTED BY FDA

香港交易所 ·  Dec 20, 2023 23:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more